Patent Assignment
Reel/Frame 040003/0579
Corrective Assignment to Correct the Assignee's Address Previously Recorded on Reel 039481 Frame 0233. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2016-08-29
Pages: 29
Assignors
NOVARTIS AG
Executed: 2016-07-01
NOVARTIS PHARMA AG
Executed: 2016-07-01
SPEEDEL HOLDING AG
Executed: 2016-07-01
Assignee
NODEN PHARMA DAC
56 FITZWILLIAM SQUARE, DUBLIN 2, IRELAND
Covered Properties
(20)
Delta-Amino-Gamma-Hydroxy-Omega-Aryl-Alkanoic Acid Amides
Patent:
5,559,111 →
Application:
08/416,242 →
Production of N-Substituted 2,7-Dialkyl-4-Hydroxy-5-Amino-8-Aryl-Octanoylamides
Patent:
7,009,078 →
Application:
10/048,229 →
2-Alkyl-5-Halogen-Pent-4-Ene Carboxylic Acids and Their Production
Patent:
6,777,574 →
Application:
10/048,290 →
Process for the Preparation of Substituted Octanoyl Amides
Process for the Preparation of Substituted Octanoyl Amides
Combination Comprising a Renin Inhibitor and an Angiotensin Receptor Inhibitor for Hypertension
Patent:
8,168,616 →
Application:
10/416,039 →
Process for the Preparation of Substituted Carboxylic Esters
Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
Application:
10/515,817 →
Publication:
US 2005/0147629
Galenic Formulations of Organic Compounds
Galenic Formulations of Organic Compounds
Preparation of N-Substituted 2,7-Dialkyl-4-Hydroxy-5-Amino-8-Aryl-Octanoyl Amides
3-Alkyl-5- (4-Alkyl-5-Oxo-Tetrahydrofutran-2-Yl) Pyrrolidin-2-One Derivatives as Intermediates in the Synthesis of Renin Inhibitors
Pharmaceutical Composition Comprising a Renin Inhibitor, a Calcium Channel Blocker and a Diuretic
Galenical Formulations of Organic Compounds
Methods for the Production of C-8 Lactam Lactone Compounds
3-Alkyl-5- (4-Alkyl-5-Oxo-Tetrahydrofutran-2-Yl) Pyrrolidin-2-One Derivatives as Intermediates in the Synthesis of Renin Inhibitors
Galenical Formulations of Organic Compounds
Synergistic Combinations Comprising a Renin Inhibitor for Cardiovascular Diseases
Synergistic Combinations Comprising a Renin Inhibitor for Cardiovascular Diseases
Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 29, 1996
From: GOSCHKE, RICHARD; MAIBAUM, JURGEN KLAUS; SCHILLING, WALTER; STUTZ, STEFAN
To: CIBA-GEIGY CORPORATION
Reel/Frame 007916/0856 →
Change of Name
Aug 22, 2000
From: CIBA-GEIGY CORPORATION
To: NOVARTIS CORPORATION
Reel/Frame 011089/0648 →
Assignment of Assignor's Interest
Jan 3, 2003
From: STUTZ, STEFAN; HEROLD, PETER; SPINDLER, FELIX
To: SPEEDEL PHARMA AG
Reel/Frame 013816/0328 →
Assignment of Assignor's Interest
Jan 24, 2003
From: STUTZ, STEFAN; HEROLD, PETER
To: SPEEDEL PHARMA AG
Reel/Frame 014134/0464 →
Assignment of Assignor's Interest
Nov 14, 2003
From: HEROLD, PETER; STUTZ, STEFAN
To: SPEEDEL PHARMA AG
Reel/Frame 015111/0286 →
Assignment of Assignor's Interest
Jun 17, 2004
From: HEROLD, PETER; STUTZ, STEFAN
To: SPEEDEL PHARMA AG
Reel/Frame 015472/0700 →
Assignment of Assignor's Interest
Nov 26, 2004
From: RIEDL, JUTTA; KANNAH, SATISH; DIETERLE, WALTER
To: SPEEDEL PHARMA AG
Reel/Frame 016414/0291 →
Assignment of Assignor's Interest
Oct 21, 2005
From: HEROLD, PETER; STUTZ, STEFAN; INDOLESE, ADRIANO
To: SPEEDEL PHARMA AG
Reel/Frame 017120/0712 →
Change of Assignee Address
Mar 6, 2006
From: SPEEDEL PHARMA AG
To: SPEEDEL PHARMA AG
Reel/Frame 017640/0422 →
Assignment of Assignor's Interest
Jan 30, 2008
From: RIGASSI-DIETRICH, PETRA GISELA; SCHMID, MARTIN
To: NOVARTIS AG
Reel/Frame 020435/0706 →
Assignment of Assignor's Interest
Jun 23, 2010
From: SEDELMEIER, GOTTFRIED; GRIMLER, DOMINIQUE; ACEMOGLU, MURAT
To: NOVARTIS AG
Reel/Frame 024583/0083 →
Assignment of Assignor's Interest
Sep 23, 2010
From: FELDMAN, DAVID LOUIS; WEBB, RANDY LEE
To: NOVARTIS AG
Reel/Frame 025032/0365 →
Assignment of Assignor's Interest
Mar 17, 2011
From: VALAZZA, STEPHEN; WAGNER, ROBERT FRANK; VIPPAGUNTA, SUDHA
To: NOVARTIS AG
Reel/Frame 025973/0991 →
Assignment of Assignor's Interest
Mar 23, 2011
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 026002/0790 →
Assignment of Assignor's Interest
Mar 23, 2012
From: HEWITT, WILLIAM; VASELLA, DANIEL LUCIUS; WEBB, RANDY LEE
To: NOVARTIS AG
Reel/Frame 027916/0852 →
Assignment of Assignor's Interest
Nov 9, 2012
From: SEDELMEIER, GOTTFRIED
To: NOVARTIS AG
Reel/Frame 029272/0078 →
Assignment of Assignor's Interest
Nov 22, 2013
From: WILLMANN, MATTHIAS
To: NOVARTIS AG
Reel/Frame 031655/0330 →
Assignment of Assignor's Interest
Apr 3, 2015
From: HEWITT, WILLIAM; VASELLA, DANIEL LUCIUS; WEBB, RANDY LEE
To: NOVARTIS AG
Reel/Frame 035328/0383 →
Assignment of Assignor's Interest
Jul 26, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 039481/0233 →
Change of Address
Mar 21, 2017
From: NODEN PHARMA DAC
To: NODEN PHARMA DAC
Reel/Frame 042084/0980 →
Security Interest
Nov 9, 2020
From: NODEN PHARMA DESIGNATED ACTIVITY COMPANY
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 054316/0730 →
Security Interest
Sep 30, 2022
From: NODEN PHARMA DESIGNATED ACTIVITY COMPANY
To: KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT
Reel/Frame 061271/0832 →
Release of Security Interest
Jan 13, 2026
From: KROLL TRUSTEE SERVICES LIMITED
To: LXO IRELAND DESIGNATED ACTIVITY COMPANY (PREVIOUSLY NODEN PHARMA DESIGNATED ACTIVITY COMPANY)
Reel/Frame 073455/0590 →
Security Interest
Apr 27, 2026
From: LXO IRELAND DESIGNATED ACTIVITY COMPANY
To: KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT
Reel/Frame 074483/0163 →